Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
Baidu
BIDU
|
+$1.13B |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$741M |
| 4 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$562M |
| 5 |
Tencent Music
TME
|
+$447M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.36B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.02B |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$553M |
| 4 |
Alibaba
BABA
|
+$541M |
| 5 |
Apple
AAPL
|
+$433M |
Sector Composition
| 1 | Consumer Discretionary | 16.07% |
| 2 | Technology | 11.34% |
| 3 | Communication Services | 11.13% |
| 4 | Healthcare | 5.99% |
| 5 | Financials | 5.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Invesco S&P 500 Equal Weight ETF
RSP
$74.2B
| $10.3M | 0.01% |
+72,678
| New | +$10.3M |
|
477
eBay
EBAY
$41.7B
| $10.3M | 0.01% |
168,046
-68,068
| -29% | -$4.17M |
|
478
Aptiv
APTV
$17.8B
| $10.3M | 0.01% |
74,362
+69,021
| +1,292% | +$9.52M |
|
479
iShares MSCI Australia ETF
EWA
$1.54B
| $10.2M | 0.01% |
412,224
+127,294
| +45% | +$3.16M |
|
480
Canadian National Railway
CNI
$57.7B
| $10.1M | 0.01% |
87,217
+8,520
| +11% | +$988K |
|
481
VICI Properties
VICI
$35.3B
| $10.1M | 0.01% |
356,455
+341,960
| +2,359% | +$9.66M |
|
|
LGV.U
482
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
| $10M | 0.01% |
+1,000,000
| New | +$10M |
|
|
RTPYU
483
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
| $10M | 0.01% |
+1,000,000
| New | +$10M |
|
484
Western Digital
WDC
$33B
| $10M | 0.01% |
198,336
-547,157
| -73% | -$27.6M |
|
|
TIGR
485
UP Fintech Holding
TIGR
$1.99B
| $10M | 0.01% |
562,394
+550,479
| +4,620% | +$9.79M |
|
486
Medical Properties Trust
MPW
$2.77B
| $9.96M | ﹤0.01% |
468,108
+387,920
| +484% | +$8.25M |
|
487
Booking.com
BKNG
$177B
| $9.95M | ﹤0.01% |
4,270
-407
| -9% | -$948K |
|
|
ONC
488
BeOne Medicines Ltd. American Depositary Shares
ONC
$34.5B
| $9.91M | ﹤0.01% |
28,476
+10,104
| +55% | +$3.52M |
|
489
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$341M
| $9.9M | ﹤0.01% |
174,970
+75,290
| +76% | +$4.26M |
|
490
iShares Genomics Immunology and Healthcare ETF
IDNA
$113M
| $9.88M | ﹤0.01% |
216,041
+182,225
| +539% | +$8.33M |
|
491
Baxter International
BAX
$12.3B
| $9.87M | ﹤0.01% |
117,046
+109,141
| +1,381% | +$9.21M |
|
492
Southwest Airlines
LUV
$16.3B
| $9.83M | ﹤0.01% |
161,006
-570,134
| -78% | -$34.8M |
|
493
Bionano Genomics
BNGO
$23M
| $9.8M | ﹤0.01% |
2,021
+1,421
| +237% | +$6.89M |
|
494
Equity Lifestyle Properties
ELS
$11.7B
| $9.74M | ﹤0.01% |
153,083
+131,673
| +615% | +$8.38M |
|
495
Procter & Gamble
PG
$368B
| $9.66M | ﹤0.01% |
71,321
+24,790
| +53% | +$3.36M |
|
496
Franklin Senior Loan ETF
FLBL
$1.21B
| $9.6M | ﹤0.01% |
+386,587
| New | +$9.6M |
|
497
Edwards Lifesciences
EW
$46B
| $9.6M | ﹤0.01% |
114,725
+61,133
| +114% | +$5.11M |
|
498
HEICO
HEI
$44.1B
| $9.52M | ﹤0.01% |
75,709
+72,136
| +2,019% | +$9.07M |
|
499
Entegris
ENTG
$12B
| $9.51M | ﹤0.01% |
85,055
+54,248
| +176% | +$6.07M |
|
500
West Pharmaceutical
WST
$18.4B
| $9.51M | ﹤0.01% |
33,751
+27,970
| +484% | +$7.88M |
|